nicardipine has been researched along with Myotonia in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Myotonia: Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insertion myotonia is ceased by addition of the Na channel blocker tetrotoxin." | 1.28 | [Intracellular recording of myotonia in mdx mouse and the effect of Ca antagonist in myotonia]. ( Kinoshita, M; Kishi, M; Kurihara, T; Uchida, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishi, M | 1 |
| Kurihara, T | 1 |
| Uchida, H | 1 |
| Kinoshita, M | 1 |
1 other study available for nicardipine and Myotonia
| Article | Year |
|---|---|
[Intracellular recording of myotonia in mdx mouse and the effect of Ca antagonist in myotonia].
Topics: Animals; Calcium Channel Blockers; In Vitro Techniques; Membrane Potentials; Mice; Muscles; Myotonia | 1989 |